H. R. 7776—955 
complementary or successor indicators of global health 
security and pandemic preparedness; and 
(ii) demonstrated commitment to transparency, 
including budget and global health data transparency, 
complying with the International Health Regulations 
(2005), investing in domestic health systems, and 
achieving measurable results; 
(E) reduce long-term reliance upon United States for-
eign assistance for global health security by— 
(i) ensuring that United States global health 
assistance authorized under this subtitle is strategi-
cally planned and coordinated in a manner that 
delivers immediate impact and contributes to enduring 
results, including through efforts to enhance commu-
nity capacity and resilience to infectious disease 
threats and emergencies; and 
(ii) ensuring partner country ownership of global 
health security strategies, data, programs, and out-
comes and improved domestic resource mobilization, 
co-financing, and appropriate national budget alloca-
tions for global health security and pandemic preven-
tion, preparedness, and response; 
(F) assist partner countries in building the technical 
capacity of relevant ministries, systems, and networks to 
prepare, execute, monitor, and evaluate national action 
plans for global health security and pandemic prevention, 
preparedness, and response that are developed with input 
from key stakeholders, including mechanism to enhance 
budget and global health data transparency, as necessary 
and appropriate; 
(G) support and align United States foreign assistance 
authorized under this subtitle with such national action 
plans for health security and pandemic prevention, 
preparedness, and response, as appropriate; 
(H) facilitate communication and collaboration, as 
appropriate, among local stakeholders in support of 
country-led strategies and initiatives to better identify and 
prevent 
health 
impacts 
related 
to 
the 
emergence, 
reemergence, and spread of zoonoses; 
(I) support the long-term success of programs by 
building the pandemic preparedness capacity of local 
organizations and institutions in target countries and 
communities; 
(J) develop community resilience to infectious disease 
threats and emergencies; 
(K) support global health budget and workforce plan-
ning in partner countries, consistent with the purposes 
of this subtitle, including training in financial management 
and budget and global health data transparency; 
(L) 
strengthen 
linkages 
between 
complementary 
bilateral and multilateral foreign assistance programs, 
including efforts of the World Bank, the World Health 
Organization, the Global Fund to Fight AIDS, Tuberculosis, 
and Malaria, and Gavi, the Vaccine Alliance, that con-
tribute to the development of more resilient health systems 
and global supply chains for global health security and 
pandemic prevention, preparedness, and response in
H. R. 7776—956 
partner countries with the capacity, resources, and per-
sonnel required to prevent, detect, and respond to infectious 
disease threats; and 
(M) support innovation and partnerships with the pri-
vate sector, health organizations, civil society, nongovern-
mental, faith-based and indigenous organizations, and 
health research and academic institutions to improve pan-
demic prevention, preparedness, and response, including 
for the development and deployment of effective and acces-
sible infectious disease tracking tools, diagnostics, thera-
peutics, and vaccines. 
(2) SUBMISSION OF STRATEGY.— 
(A) IN GENERAL.—Not later than 180 days after the 
date of the enactment of this Act, the President, in con-
sultation with the heads of the relevant Federal depart-
ments and agencies, shall submit the strategy required 
under paragraph (1) to— 
(i) the appropriate congressional committees; 
(ii) the Committee on Health, Education, Labor, 
and Pensions of the Senate; and 
(iii) the Committee on Energy and Commerce of 
the House of Representatives. 
(B) AGENCY-SPECIFIC
PLANS.—The strategy required 
under paragraph (1) shall include specific implementation 
plans from each relevant Federal department and agency 
that describe— 
(i) the anticipated contributions of the Federal 
department or agency, including technical, financial, 
and in-kind contributions, to implement the strategy; 
and 
(ii) the efforts of the Federal department or agency 
to ensure that the activities and programs carried out 
pursuant to the strategy are designed to achieve max-
imum impact and long-term sustainability. 
(3) ANNUAL REPORT.— 
(A) IN
GENERAL.—Not later than 1 year after the 
submission of the strategy pursuant to paragraph (2)(A), 
and not later than October 1 of each year thereafter, the 
President shall submit to the committees listed in such 
paragraph a report that describes the status of the 
implementation of such strategy. 
(B) CONTENTS.—Each report submitted pursuant to 
subparagraph (A) shall— 
(i) identify any substantial changes made to the 
strategy during the preceding calendar year; 
(ii) describe the progress made in implementing 
the strategy, including specific information related to 
the progress toward improving countries’ ability to 
detect, prevent, and respond to infectious disease 
threats; 
(iii) identify— 
(I) the indicators used to establish benchmarks 
and measure results over time; and 
(II) the mechanisms for reporting such results 
in an open and transparent manner;
H. R. 7776—957 
(iv) contain a transparent, open, and detailed 
accounting of obligations by relevant Federal depart-
ments and agencies to implement the strategy, 
including, to the extent practicable, for each such Fed-
eral department and agency, the statutory source of 
obligated funds, the amounts obligated, implementing 
partners and sub-partners, targeted beneficiaries, and 
activities supported; 
(v) the efforts of the relevant Federal department 
or agency to ensure that the activities and programs 
carried out pursuant to the strategy are designed to 
achieve maximum impact and enduring results, 
including through specific activities to strengthen 
health systems for global health security and pandemic 
prevention, preparedness, and response, as appro-
priate; 
(vi) assess efforts to coordinate United States 
global health security programs, activities, and initia-
tives with key stakeholders; 
(vii) incorporate a plan for regularly reviewing and 
updating strategies, partnerships, and programs and 
sharing lessons learned with a wide range of stake-
holders in an open, transparent manner; and 
(viii) describe the progress achieved and challenges 
concerning the United States Government’s ability to 
advance the Global Health Security Agenda and pan-
demic preparedness, including data disaggregated by 
priority country using indicators that are consistent 
on a year-to-year basis and recommendations to 
resolve, mitigate, or otherwise address the challenges 
identified through such indicators. 
(C) FORM.—The strategy and reports required under 
this subsection shall be submitted in unclassified form, 
but may contain a classified annex. 
(b) UNITED STATES COORDINATOR FOR GLOBAL HEALTH SECU-
RITY.—The President shall designate an appropriate senior official 
to be the United States Coordinator for Global Health Security, 
who shall be responsible for the coordination of the Global Health 
Security Agenda Interagency Review Council and who should— 
(1) have significant background and expertise in public 
health, health security, and emergency response management; 
(2) coordinate, through a whole-of-government approach, 
the efforts of relevant Federal departments and agencies to 
implement the strategy under subsection (a); and 
(3) seek to fully use the unique capabilities of each relevant 
Federal department and agency and ensure effective and appro-
priate United States representation at relevant international 
forums, while collaborating with and leveraging the contribu-
tions of other key stakeholders. 
(c) AMBASSADOR-AT-LARGE FOR GLOBAL HEALTH SECURITY AND 
DIPLOMACY.— 
(1) ESTABLISHMENT.—There is established, within the 
Department of State, the position of Ambassador-At-Large for 
Global Health Security and Diplomacy (referred to in this sec-
tion as the ‘‘Ambassador-At-Large’’). 
(2) APPOINTMENT; QUALIFICATIONS.—The Ambassador-At- 
Large—
H. R. 7776—958 
(A) shall be appointed by the President, by and with 
the advice and consent of the Senate; 
(B) shall report to the Secretary of State; and 
(C) shall have— 
(i) demonstrated knowledge and experience in the 
field of health security, development, public health, 
epidemiology, or medicine; and 
(ii) relevant diplomatic, policy, and political exper-
tise. 
(3) AUTHORITIES.—The Ambassador-At-Large may— 
(A) operate internationally to carry out the purposes 
of this section; 
(B) ensure effective coordination, management, and 
oversight of United States foreign policy, diplomatic efforts, 
and foreign assistance funded with amounts authorized 
to be appropriated pursuant to section 5564(a) that are 
used by the Department of State to advance the relevant 
elements of the United States global health security and 
diplomacy strategy developed pursuant to subsection (a) 
by— 
(i) developing and updating, as appropriate, in 
collaboration with the Administrator of the USAID 
and the Secretary of Health and Human Services, 
related policy guidance and unified auditing, moni-
toring, and evaluation plans; 
(ii) avoiding duplication of effort and collaborating 
with other relevant Federal departments and agencies; 
(iii) leading, in collaboration with the Secretary 
of Health and Human Services, the Administrator of 
the USAID, and other relevant Federal departments 
and agencies, diplomatic efforts to identify and address 
current and emerging threats to global health security; 
(iv) working to enhance coordination with, and 
transparency among, the governments of partner coun-
tries and key stakeholders, including the private sector; 
(v) promoting greater donor and national invest-
ment in partner countries to build health systems and 
supply chains for global health security and pandemic 
prevention and preparedness; 
(vi) securing bilateral and multilateral financing 
commitments to advance the Global Health Security 
Agenda, in coordination with relevant Federal depart-
ments and agencies, including through funding for the 
Financial Intermediary Fund for Pandemic Prevention, 
Preparedness, and Response; and 
(vii) providing regular updates to the appropriate 
congressional committees, the Committee on Health, 
Education, Labor, and Pensions of the Senate, and 
the Committee on Energy and Commerce of the House 
of Representatives regarding the fulfillment of the 
activities described in this paragraph; 
(C) ensure, in collaboration with the Secretary of the 
Treasury, the Secretary of Health and Human Services, 
and the Administrator of the USAID, effective representa-
tion of the United States in the Financial Intermediary 
Fund 
for 
Pandemic 
Prevention, 
Preparedness, 
and 
Response;